Patents by Inventor Aravind Prasad Medikonda

Aravind Prasad Medikonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED BENZAMIDES AS MODULATORS OF TREX1
    Publication number: 20230233541
    Abstract: Provided are compounds of Formula (I): (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with TREX1.
    Type: Application
    Filed: May 27, 2021
    Publication date: July 27, 2023
    Inventors: Mary-Margaret Zablocki, Kennedy Taveras, Jonathan E. Wilson, Aaron Coffin, Julian R. Levell, Aravind Prasad Medikonda
  • Ligand-directed covalent modification of protein
    Patent number: 11542492
    Abstract: The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: January 3, 2023
    Assignee: Celgene CAR LLC
    Inventors: Russell C. Petter, Charles F. Jewell, Kwangho Lee, Aravind Prasad Medikonda, Deqiang Niu, Lixin Qiao, Juswinder Singh, Zhendong Zhu
  • Ligand-Directed Covalent Modification of Protein
    Publication number: 20170218353
    Abstract: The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
    Type: Application
    Filed: February 2, 2017
    Publication date: August 3, 2017
    Inventors: Russell C. Petter, Charles F. Jewell, Kwangho Lee, Aravind Prasad Medikonda, Deqiang Niu, Lixin Qiao, Juswinder Singh, Zhendong Zhu
  • LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
    Publication number: 20110269244
    Abstract: The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
    Type: Application
    Filed: December 30, 2010
    Publication date: November 3, 2011
    Inventors: Russell C. Petter, Charles F. Jewell, Kwangho Lee, Aravind Prasad Medikonda, Deqiang Niu, Lixin Qiao, Juswinder Singh, Zhendong Zhu